Rita Keynan

Corporate Officer/Principal chez PAINREFORM LTD.

Health Technology

Consumer Services

Postes actifs de Rita Keynan

Sociétés	Poste	Début	Fin
PAINREFORM LTD.	Corporate Officer/Principal	06/01/2021	-

Sociétés	Poste	Début	Fin
VYNE Pharmaceuticals Ltd. VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.	Corporate Officer/Principal	-	-

The Hebrew University of Jerusalem

Graduate Degree

Internationale

Israël

Opérationnelle

Corporate Officer/Principal	2
Graduate Degree	1
Undergraduate Degree	1

Sectorielle

Health Technology	3
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
PAINREFORM LTD.	Health Technology

Entreprise privées	1
VYNE Pharmaceuticals Ltd. VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.	Health Technology

Entreprise privées

Health Technology